scholarly article | Q13442814 |
P356 | DOI | 10.2217/EBO.11.96 |
P50 | author | Domenica Lorusso | Q38524419 |
Giovanni Scambia | Q91909477 | ||
P2093 | author name string | Antonella Pietragalla | |
P2860 | cites work | Results from four rounds of ovarian cancer screening in a randomized trial | Q24650747 |
Cancer statistics, 2009 | Q29547625 | ||
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Q33957687 | ||
International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma | Q33963742 | ||
Early events in the pathogenesis of epithelial ovarian cancer | Q37057044 | ||
MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization | Q37679517 | ||
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer. | Q43048172 | ||
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer | Q44461877 | ||
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial | Q46221067 | ||
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. | Q53227029 | ||
Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. | Q53300225 | ||
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 198-210 | |
P577 | publication date | 2012-03-01 | |
P1476 | title | Guidelines in ovarian cancer |
Search more.